ATE531791T1 - Verfahren zur gewinnung menschlicher glatter muskelzellen und verwendungen davon - Google Patents

Verfahren zur gewinnung menschlicher glatter muskelzellen und verwendungen davon

Info

Publication number
ATE531791T1
ATE531791T1 AT06808166T AT06808166T ATE531791T1 AT E531791 T1 ATE531791 T1 AT E531791T1 AT 06808166 T AT06808166 T AT 06808166T AT 06808166 T AT06808166 T AT 06808166T AT E531791 T1 ATE531791 T1 AT E531791T1
Authority
AT
Austria
Prior art keywords
cells
smooth muscular
concerns
muscular
human
Prior art date
Application number
AT06808166T
Other languages
English (en)
Inventor
Ricousse Sophie Le
Marie-Noelle Lacassagne
Jean-Pierre Marolleau
Original Assignee
Assist Publ Hopitaux De Paris
Inst Vaisseaux Et Du Sang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assist Publ Hopitaux De Paris, Inst Vaisseaux Et Du Sang filed Critical Assist Publ Hopitaux De Paris
Application granted granted Critical
Publication of ATE531791T1 publication Critical patent/ATE531791T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0661—Smooth muscle cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/165—Vascular endothelial growth factor [VEGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
    • C12N2506/1323—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from skeletal muscle cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Cell Biology (AREA)
  • Cardiology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Excavating Of Shafts Or Tunnels (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT06808166T 2005-09-19 2006-09-19 Verfahren zur gewinnung menschlicher glatter muskelzellen und verwendungen davon ATE531791T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0509557A FR2890977A1 (fr) 2005-09-19 2005-09-19 Procede d'obtention de cellules musculaires lisses humaines et leurs applications
PCT/FR2006/002144 WO2007034069A1 (fr) 2005-09-19 2006-09-19 Procede d'obtention de cellules musculaires lisses humaines et leurs applications

Publications (1)

Publication Number Publication Date
ATE531791T1 true ATE531791T1 (de) 2011-11-15

Family

ID=36587333

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06808166T ATE531791T1 (de) 2005-09-19 2006-09-19 Verfahren zur gewinnung menschlicher glatter muskelzellen und verwendungen davon

Country Status (10)

Country Link
US (1) US20090269310A1 (de)
EP (1) EP1934333B9 (de)
JP (1) JP2009508511A (de)
CN (1) CN101310013B (de)
AT (1) ATE531791T1 (de)
AU (1) AU2006293814B2 (de)
CA (1) CA2622916A1 (de)
FR (1) FR2890977A1 (de)
IL (1) IL190289A0 (de)
WO (1) WO2007034069A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2909559B1 (fr) * 2006-12-06 2012-09-07 Inst Vaisseaux Et Du Sang Preparations cellulaires pour une utilisation comme agent stimulant la revascularisation
EP3461507A1 (de) * 2008-11-04 2019-04-03 inRegen Zellträgerkonstrukte
RS64241B1 (sr) * 2017-12-14 2023-06-30 Innovacell Ag Postupci za dobijanje ćelija izvedenih iz mišića
CN112119155A (zh) * 2018-05-08 2020-12-22 苏黎士大学 用于无异种产生hMPC群的方法
US20220145257A1 (en) * 2019-03-22 2022-05-12 Innovacell Ag Methods for obtaining induced smooth muscle cells
WO2024143453A1 (ja) * 2022-12-28 2024-07-04 インターステム株式会社 細胞組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2810045B1 (fr) * 2000-06-07 2004-09-03 Assist Publ Hopitaux De Paris Procede d'obtention de population cellulaires caracterisees d'origine musculaire et utilisations
US20040247575A1 (en) * 2003-06-03 2004-12-09 Caplice Noel M. Smooth muscle progenitor cells

Also Published As

Publication number Publication date
JP2009508511A (ja) 2009-03-05
IL190289A0 (en) 2011-08-01
AU2006293814B2 (en) 2011-09-29
EP1934333B1 (de) 2011-11-02
AU2006293814A1 (en) 2007-03-29
CA2622916A1 (fr) 2007-03-29
WO2007034069A1 (fr) 2007-03-29
EP1934333B9 (de) 2012-05-02
US20090269310A1 (en) 2009-10-29
CN101310013B (zh) 2011-09-07
EP1934333A1 (de) 2008-06-25
CN101310013A (zh) 2008-11-19
FR2890977A1 (fr) 2007-03-23

Similar Documents

Publication Publication Date Title
ATE531791T1 (de) Verfahren zur gewinnung menschlicher glatter muskelzellen und verwendungen davon
WO2007035843A3 (en) Methods and compositions for organ and tissue functionality
EP2447280A3 (de) VEGF Analoga und Verfahren zur Verwendung davon
EA200900177A1 (ru) Замещенные ациланилиды и способы их применения
IL177015B (en) Isolated human rpe cells and their use for the treatment of retinal degenerative diseases
WO2006081435A3 (en) Method of providing readily available cellular material derived from cord blood, and a composition thereof
WO2002008389A3 (en) Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue
CL2004000639A1 (es) Compuestos derivados de quinolina y quinoxalina, composicion farmaceutica, combinacion farmaceutica; kit farmaceutico; y su uso para tratar aterosclerosis, enfermedad de arteria coronaria, enfermedad cardiaca coronaria, enfermedad vascular coronaria,
EP2465921A3 (de) Herzstammzellen aus der Biopsie
WO2003040346A3 (en) Methods and compositions for the use of stromal cells to support embryonic and adult stem cells
GB0504988D0 (en) Device and method for the treatment of diseased tissue such as tumors
HK1118577A1 (en) Rnai expression constructs rnai
WO2004113571A3 (en) Prostate specific genes and the use thereof as targets for prostate cancer therapy and diagnosis
MX2009012666A (es) Composicion para el tratamiento de enfermedades isquemicas de las extremidades que se componen de celulas madre derivadas de tejido adiposo.
TR201903587T4 (tr) Telomeraz aktivitesinin artırılması için bileşimler.
WO2008150490A3 (en) Uses and compositions for treatment of psoriasis and crohn's disease
WO2006093857A3 (en) Method of providing readily available cellular material derived from peripheral blood and a composition thereof
WO2004047747A3 (en) Compositions and methods for cell dedifferentiation and tissue regeneration
IS7770A (is) Hlutleysandi mótefni gegn GDF-8 og notkun theirra
WO2006093967A3 (en) Compositions and methods for targeting or imaging a tissue in a vertebrate subject
DE602005026866D1 (de) Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen
ITMI20041550A1 (it) Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide
ATE473735T1 (de) Beta-2 adrenoceptor agonisten zur behandlung von bindegewebserkrankungen der haut
BRPI0912292A2 (pt) composições e métodos para o uso de células no tratamento do tecido cardíaco.
WO2006014999A3 (en) Compositions and methods of use for modulators of nectin 4, semaphorin 4b, igsf9, and kiaa0152 in treating disease